FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mohamad Navab

Research Profile

Chemicals & Drugs

Living Beings

Phenomena

Oxidation-Reduction

Anatomy

Disorders

Concepts & Ideas

Atherogenic Diet

Co-author Network

Publications

TOP 3
Rongsong Li; Todd E Morgan; Kaveh Navab; Mohamad Navab; Zhi Ning; Payam Pakbin; Constantinos Sioutas; Jesus A Araujo; Caleb E Finch; Alan M Fogelman; Greg Hough; Tzung K Hsiai
Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice.
Fen Yin; Alan M Fogelman; Julie R Fox; Tim Larson; Akeem Lawal; Mohamad Navab; Jerry Ricks; Michael E Rosenfeld; Jesus A Araujo
Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional pro-oxidant and pro-inflammatory high-density lipoprotein.
Arnab Chattopadhyay; Robin Farias-Eisener; Gm Anantharamaiah; Feng Gao; Victor Grijalva; Greg Hough; David Meriwether; Ryan Namiri-Kalantari; Mohamad Navab; Mayakonda N Palgnachari; Srinivasa T Reddy; James R Springstead; Feng Su; Brian J Van Lenten; Alan C Wagner; Alan M Fogelman
A novel approach to oral apoA-I mimetic therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mohamad Navab (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rongsong Li; Todd E Morgan; Kaveh Navab; Mohamad Navab; Zhi Ning; Payam Pakbin; Constantinos Sioutas; Jesus A Araujo; Caleb E Finch; Alan M Fogelman; Greg Hough; Tzung K Hsiai
Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice.
Journal of lipid research 2013;54(6):1608-15.
2013: Fen Yin; Alan M Fogelman; Julie R Fox; Tim Larson; Akeem Lawal; Mohamad Navab; Jerry Ricks; Michael E Rosenfeld; Jesus A Araujo
Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional pro-oxidant and pro-inflammatory high-density lipoprotein.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(6):1153-61.
2013: Arnab Chattopadhyay; Robin Farias-Eisener; Gm Anantharamaiah; Feng Gao; Victor Grijalva; Greg Hough; David Meriwether; Ryan Namiri-Kalantari; Mohamad Navab; Mayakonda N Palgnachari; Srinivasa T Reddy; James R Springstead; Feng Su; Brian J Van Lenten; Alan C Wagner; Alan M Fogelman
A novel approach to oral apoA-I mimetic therapy.
Journal of lipid research 2013;54(4):995-1010.
2013: Mohamad Navab; Maryam Haghnegahdar; Kaveh Daniel Navab; Maryam Shabihkhani; Samra Vazirian; Srinivasa T Reddy
Reducing plasma cholesterol is not the end of the quest.
Atherosclerosis 2013;227(1):35-6.
2013: Rongsong Li; David Mittelstein; Mohamad Navab; Payam Pakbin; Constantinos Sioutas; Yin Tintut; Yunfeng Du; Winnie Kam; Tzung K Hsiai
Atmospheric ultrafine particles promote vascular calcification via the NF-κB signaling pathway.
American journal of physiology. Cell physiology 2013;304(4):C362-9.
2012: Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Alan C Wagner; Georgette M Buga; Greg Hough; Alan M Fogelman
High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(11):2553-60.
2012: Feng Gao; Victor Grijalva; Mohamad Navab; Srinivasa T Reddy; Feng Su; Arnab Chattopadhyay; Alan M Fogelman; Robin Farias-Eisner
Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model.
The Journal of pharmacology and experimental therapeutics 2012;342(2):255-62.
2012: Feng Su; Alan M Fogelman; Ekambaram Ganapathy; Victor Grijalva; Satoshi Imaizumi; David Meriwether; Kaveh Navab; Mohamad Navab; Srinivasa T Reddy; Robin Farias-Eisner
HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer.
Molecular cancer therapeutics 2012;11(6):1311-9.
2012: Mohamad Navab; Srinivasa T Reddy; Greg Hough; Gm Anantharamaiah; Georgette M Buga; Jan Danciger; Alan M Fogelman
D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice.
Journal of lipid research 2012;53(3):437-45.
2012: THEODOROS KELESIDIS; David Meriwether; Mohamad Navab; Srinivasa T Reddy; Alan M Fogelman; Diana Huynh; Otto O Yang
Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.
Lipids in health and disease 2012;11():87.
2011: THEODOROS KELESIDIS; David Meriwether; Mohamad Navab; Srinivasa T Reddy; Christina Charles-Schoeman; Judith S Currier; Alan M Fogelman; Diana Huynh; Otto O Yang
A biochemical fluorometric method for assessing the oxidative properties of HDL.
Journal of lipid research 2011;52(12):2341-51.
2011: Cecilia Morgantini; Andrea Natali; Mohamad Navab; Beatrice Boldrini; Ele Ferrannini; Alan M Fogelman; Satoshi Imaizumi; Srinivasa T Reddy
Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes.
Diabetes 2011;60(10):2617-23.
2011: David Meriwether; Mohamad Navab; Srinivasa T Reddy; Gm Anantharamaiah; Robin Farias-Eisner; Alan M Fogelman; Victor Grijalva; Greg Hough; Satoshi Imaizumi; Ladan Vakili; Ishaiahu Shechter
Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma.
Journal of lipid research 2011;52(10):1795-809.
2011: Mohamad Navab; Srinivasa T Reddy; Gm Anantharamaiah; Satoshi Imaizumi; Greg Hough; Susan Hama; Alan M Fogelman
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.
Journal of lipid research 2011;52(6):1200-10.
2011: Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Alan M Fogelman
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.
Nature reviews. Cardiology 2011;8(4):222-32.
2011: Feng Gao; Sergio Vasquez; Feng Su; Svetlana Roberts; Neha Shah; Victor Grijalva; Satoshi Imaizumi; Arnab Chattopadhyay; Ekambaram Ganapathy; David Meriwether; Brad Johnston; Gm Anantharamaiah; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Integrative biology : quantitative biosciences from nano to macro 2011;3(4):479-89.
2011: Asokan Devarajan; Noam Bourquard; Susan Hama; Mohamad Navab; Victor Grijalva; Susan Morvardi; Catherine F Clarke; Laurent Vergnes; Karen Reue; John F Teiber; Srinivasa T Reddy
Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis.
Antioxidants & redox signaling 2011;14(3):341-51.
2011: Satoshi Imaizumi; Murray Kwon; David Meriwether; Cecilia Morgantini; Mohamad Navab; Christina Charles-Schoeman; Robin Farias-Eisner; Alan M Fogelman; Ekambaram Ganapathy; Feng Gao; Feng Su; Srinivasa T Reddy
Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins.
Circulation journal : official journal of the Japanese Circulation Society 2011;75(7):1533-8.
2011: Kaveh D Navab; Omeed Elboudwarej; Mackena Gharif; Jeryl Yu; Susan Y Hama; Sheila Safarpour; Greg Hough; Ladan Vakili; Srinivasa T Reddy; Mohamad Navab; Nosratola D Vaziri
Chronic inflammatory disorders and accelerated atherosclerosis: chronic kidney disease.
Current pharmaceutical design 2011;17(1):17-20.
2010: Feng Su; Katherine R Kozak; Satoshi Imaizumi; Feng Gao; Malaika W Amneus; Victor Grijalva; Carey Ng; Alan Wagner; Greg Hough; Gina Farias-Eisner; Gm Anantharamaiah; Brian J Van Lenten; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(46):19997-20002.
2010: Satoshi Imaizumi; Victor Grijalva; Saul Priceman; Lily Wu; Feng Su; Robin Farias-Eisner; Susan Hama; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.
Molecular genetics and metabolism 2010;101(1):66-75.
2010: Satoshi Imaizumi; Victor Grijalva; Mohamad Navab; Brian J Van Lenten; Alan C Wagner; G M Anantharamiah; Alan M Fogelman; Srinivasa T Reddy
L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.
Drug metabolism letters 2010;4(3):139-48.
2010: Georgette M Buga; Mohamad Navab; Satoshi Imaizumi; Srinivasa T Reddy; Babak Yekta; Greg Hough; Shawn Chanslor; Gm Anantharamaiah; Alan M Fogelman
L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(2):283-9.
2010: Mohamad Navab; Ishaiahu Shechter; Gm Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Alan M Fogelman
Structure and function of HDL mimetics.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(2):164-8.
2010: Jennifer M P Woo; Zhuofeng Lin; Mohamad Navab; Casey Van Dyck; Yvette Trejo-Lopez; Krystal M T Woo; Hongyun Li; Lawrence W Castellani; Xuping Wang; Noriko Iikuni; Ornella J Rullo; Hui Wu; Antonio La Cava; Alan M Fogelman; Aldons J Lusis; Betty P Tsao
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.
Arthritis research & therapy 2010;12(3):R93.
2010: Piotr Ruchala; Mohamad Navab; Chun-Ling Jung; Susan Hama-Levy; Ewa D Micewicz; Hai Luong; Jonathan E Reyles; Shantanu Sharma; Alan J Waring; Alan M Fogelman; Robert I Lehrer
Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids.
PloS one 2010;5(4):e10181.
2010: Ladan Vakili; Susan Hama; J Brian Kim; Duc Tien; Shila Safarpoor; Nancy Ly; Ghazal Vakili; Greg Hough; Mohamad Navab
The effect of HDL mimetic peptide 4F on PON1.
Advances in experimental medicine and biology 2010;660():167-72.
2009: Mohamad Navab; Piotr Ruchala; Alan J Waring; Robert I Lehrer; Susan Hama; Greg Hough; Mayakonda N Palgunachari; Gm Anantharamaiah; Alan M Fogelman
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
Journal of lipid research 2009;50(8):1538-47.
2009: Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Gm Anantharamaiah; Alan M Fogelman
The role of dysfunctional HDL in atherosclerosis.
Journal of lipid research 2009;50 Suppl():S145-9.
2008: Brian J Van Lenten; Mohamad Navab; Gm Anantharamaiah; Georgette M Buga; Srinivasa T Reddy; Alan M Fogelman
Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.
Current opinion in investigational drugs (London, England : 2000) 2008;9(11):1157-62.
2008: Brian J Van Lenten; Alan C Wagner; Chun-Ling Jung; Piotr Ruchala; Alan J Waring; Robert I Lehrer; Andrew D Watson; Susan Hama; Mohamad Navab; Gm Anantharamaiah; Alan M Fogelman
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.
Journal of lipid research 2008;49(11):2302-11.
2008: Daniel Cruz; Andrew D Watson; Christopher S Miller; Dennis Montoya; Maria Teresa Ochoa; Peter Allan Sieling; Miguel A Gutierrez; Mohamad Navab; Srinivasa T Reddy; Joseph L Witztum; Alan M Fogelman; Thomas H Rea; David Eisenberg; Judith A Berliner; Robert L Modlin
Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy.
The Journal of clinical investigation 2008;118(8):2917-28.
2008: Mohamad Navab; Nima Gharavi; Andrew D Watson
Inflammation and metabolic disorders.
Current opinion in clinical nutrition and metabolic care 2008;11(4):459-64.
2008: LeAnne T Bloedon; Richard Dunbar; Danielle Duffy; Paula Pinell-Salles; Robert Norris; Bruce J DeGroot; Rajesh Movva; Mohamad Navab; Alan M Fogelman; Daniel J Rader
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients.
Journal of lipid research 2008;49(6):1344-52.
2008: Christina Charles-Schoeman; Mona L Banquerigo; Susan Hama; Mohamad Navab; Grace S Park; Brian J Van Lenten; Alan C Wagner; Alan M Fogelman; Ernest Brahn
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis.
Clinical immunology (Orlando, Fla.) 2008;127(2):234-44.
2008: Roger Yu; Babak Yekta; Ladan Vakili; Nima M Gharavi; Mohamad Navab; Daniel Marelli; Abbas Ardehali
Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides.
Current atherosclerosis reports 2008;10(2):171-6.
2008: Jesus A Araujo; Berenice Barajas; Michael T Kleinman; Xuping Wang; Brian J Bennett; Ke Wei Gong; Mohamad Navab; Jack Harkema; Constantinos Sioutas; Aldons J Lusis; Andre E Nel
Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.
Circulation research 2008;102(5):589-96.
2008: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Alan M Fogelman
Apo A-1 mimetic peptides as atheroprotective agents in murine models.
Current drug targets 2008;9(3):204-9.
2008: Mohamad Navab; Gm Anantharamaiah; Alan M Fogelman
The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis.
Trends in cardiovascular medicine 2008;18(2):61-6.
2008: Georgette M Buga; Joy S Frank; Giuliano A Mottino; Ashkan Hakhamian; Ajay Narasimha; Andrew D Watson; Babak Yekta; Mohamad Navab; Srinivasa T Reddy; Gm Anantharamaiah; Alan M Fogelman
D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet.
Journal of lipid research 2008;49(1):192-205.
2007: Brian J Van Lenten; Alan C Wagner; Mohamad Navab; Gm Anantharamaiah; Susan Hama; Srinivasa T Reddy; Alan M Fogelman
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits.
Journal of lipid research 2007;48(11):2344-53.
2007: Mohamad Navab; Roger Yu; Nima M Gharavi; William Huang; Navid Ezra; Ali Lotfizadeh; Gm Anantharamaiah; Nima Alipour; Brian J Van Lenten; Srinivasa T Reddy; Daniel Marelli
High-density lipoprotein: antioxidant and anti-inflammatory properties.
Current atherosclerosis reports 2007;9(3):244-8.
2007: Gm Anantharamaiah; Vinod K Mishra; David W Garber; Geeta Datta; Shaila P Handattu; Mayakonda N Palgunachari; Manjula Chaddha; Mohamad Navab; Srinivasa T Reddy; Jere P Segrest; Alan M Fogelman
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.
Journal of lipid research 2007;48(9):1915-23.
2007: Junji Watanabe; Katherine J Chou; James C Liao; Yunan Miao; Hsiang-Hui Meng; Helen Ge; Victor Grijalva; Susan Hama; Katherine R Kozak; Georgette M Buga; Julian P Whitelegge; Terry D Lee; Robin Farias-Eisner; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis.
The Journal of biological chemistry 2007;282(32):23698-707.
2007: Ajay Narasimha; Junji Watanabe; James A Lin; Susan Hama; Robert Langenbach; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.
Prostaglandins & other lipid mediators 2007;84(1-2):24-33.
2007: Carey J Ng; Noam Bourquard; Susan Hama; Diana M Shih; Victor Grijalva; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(6):1368-74.
2007: Mohamad Navab; G M Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Georgette M Buga; Alan M Fogelman
Peptide Mimetics of Apolipoproteins Improve HDL Function.
Journal of clinical lipidology 2007;1(2):142-7.
2007: Nerses Sanossian; Jeffrey Saver; Mohamad Navab; Bruce Ovbiagele
High-density lipoprotein cholesterol: an emerging target for stroke treatment.
Stroke; a journal of cerebral circulation 2007;38(3):1104-9.
2007: Benjamin J Ansell; Gregg C Fonarow; Mohamad Navab; Alan M Fogelman
Modifying the anti-inflammatory effects of high-density lipoprotein.
Current atherosclerosis reports 2007;9(1):57-63.
2006: Carey J Ng; Susan Hama; Noam Bourquard; Mohamad Navab; Srinivasa T Reddy
Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.
Molecular genetics and metabolism 2006;89(4):368-73.
2006: Carey J Ng; Noam Bourquard; Victor Grijalva; Susan Hama; Diana M Shih; Mohamad Navab; Alan M Fogelman; Aldons J Lusis; Stephen Young; Srinivasa T Reddy
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.
The Journal of biological chemistry 2006;281(40):29491-500.
2006: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Alan M Fogelman
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention.
Nature clinical practice. Cardiovascular medicine 2006;3(10):540-7.
2006: Georgette M Buga; Joy S Frank; Giuliano A Mottino; Michael Hendizadeh; Ashkan Hakhamian; Jan H Tillisch; Srinivasa T Reddy; Mohamad Navab; Gm Anantharamaiah; Louis J Ignarro; Alan M Fogelman
D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet.
Journal of lipid research 2006;47(10):2148-60.
2006: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Alan M Fogelman
Mechanisms of disease: proatherogenic HDL--an evolving field.
Nature clinical practice. Endocrinology & metabolism 2006;2(9):504-11.
2006: Brian J Van Lenten; Srinivasa T Reddy; Mohamad Navab; Alan M Fogelman
Understanding changes in high density lipoproteins during the acute phase response.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(8):1687-8.
2006: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Geeta Datta; David W Garber; Alan M Fogelman
Potential clinical utility of high-density lipoprotein-mimetic peptides.
Current opinion in lipidology 2006;17(4):440-4.
2006: Gm Anantharamaiah; Mohamad Navab; Srinivasa T Reddy; David W Garber; Geeta Datta; Himanshu Gupta; C Roger White; Shaila P Handattu; Mayakonda N Palgunachari; Manjula Chaddha; Vinod K Mishra; Jere P Segrest; Alan M Fogelman
Synthetic peptides: managing lipid disorders.
Current opinion in lipidology 2006;17(3):233-7.
2006: Srinivasa T Reddy; Gm Anantharamaiah; Mohamad Navab; Susan Hama; Greg Hough; Victor Grijalva; David W Garber; Geeta Datta; Alan M Fogelman
Oral amphipathic peptides as therapeutic agents.
Expert opinion on investigational drugs 2006;15(1):13-21.
2005: Benjamin J Ansell; Karol E Watson; Alan M Fogelman; Mohamad Navab; Gregg C Fonarow
High-density lipoprotein function recent advances.
Journal of the American College of Cardiology 2005;46(10):1792-8.
2005: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Susan Hama; Greg Hough; Joy S Frank; Victor Grijalva; Vannakambadi K Ganesh; Vinod K Mishra; Mayakonda N Palgunachari; Alan M Fogelman
Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
Circulation research 2005;97(6):524-32.
2005: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Alan C Wagner; Susan Hama; Greg Hough; Eugene Bachini; David W Garber; Vinod K Mishra; Mayakonda N Palgunachari; Alan M Fogelman
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(9):1932-7.
2005: Mohamad Navab; Gm Anantharamaiah; Susan Hama; Greg Hough; Srinivasa T Reddy; Joy S Frank; David W Garber; Shaila P Handattu; Alan M Fogelman
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(7):1426-32.
2005: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Susan Hama; Greg Hough; Victor Grijalva; Nicholas Yu; Benjamin J Ansell; Geeta Datta; David W Garber; Alan M Fogelman
Apolipoprotein A-I mimetic peptides.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(7):1325-31.
2005: Mohamad Navab; Gm Anantharamaiah; Alan M Fogelman
The role of high-density lipoprotein in inflammation.
Trends in cardiovascular medicine 2005;15(4):158-61.
2005: Carey J Ng; Diana M Shih; Susan Hama; Natividad Villa; Mohamad Navab; Srinivasa T Reddy
The paraoxonase gene family and atherosclerosis.
Free radical biology & medicine 2005;38(2):153-63.
2005: Mohamad Navab; G M Ananthramaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Susan Hama; Greg Hough; Eugene Bachini; Victor Grijalva; Alan C Wagner; Zory Shaposhnik; Alan M Fogelman
The double jeopardy of HDL.
Annals of medicine 2005;37(3):173-8.
2004: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Geeta Datta; David W Garber; Alan M Fogelman
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal.
Current opinion in lipidology 2004;15(6):645-9.
2004: Benjamin J Ansell; Mohamad Navab; Karol E Watson; Gregg C Fonarow; Alan M Fogelman
Anti-inflammatory properties of HDL.
Reviews in endocrine & metabolic disorders 2004;5(4):351-8.
2004: Brian J Van Lenten; Alan C Wagner; Mohamad Navab; Gm Anantharamaiah; Eric Ka-Wai Hui; Debi P Nayak; Alan M Fogelman
D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.
Circulation 2004;110(20):3252-8.
2004: Srinivasa T Reddy; Julie T Nguyen; Victor Grijalva; Greg Hough; Susan Hama; Mohamad Navab; Alan M Fogelman
Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(9):1676-81.
2004: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Susan Hama; Greg Hough; Victor Grijalva; Alan C Wagner; Joy S Frank; Geeta Datta; David W Garber; Alan M Fogelman
Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Circulation 2004;109(25):3215-20.
2004: Geeta Datta; Raquel F Epand; Richard M Epand; Manjula Chaddha; Matthew A Kirksey; David W Garber; Sissel Lund-Katz; Michael C Phillips; Susan Hama; Mohamad Navab; Alan M Fogelman; Mayakonda N Palgunachari; Jere P Segrest; Gm Anantharamaiah
Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity.
The Journal of biological chemistry 2004;279(25):26509-17.
2004: Mohamad Navab; G M Ananthramaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Gregg C Fonarow; Kambiz Vahabzadeh; Susan Hama; Greg Hough; Naeimeh Kamranpour; Judith A Berliner; Aldons J Lusis; Alan M Fogelman
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
Journal of lipid research 2004;45(6):993-1007.
2004: Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Alan M Fogelman
Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a).
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):392-3.
2004: Tzung K Hsiai; Sung K Cho; Pak K Wong; Michael H Ing; Adler Salazar; Susan Hama; Mohamad Navab; Linda L Demer; Chih-Ming Ho
Micro sensors: linking real-time oscillatory shear stress with vascular inflammatory responses.
Annals of biomedical engineering 2004;32(2):189-201.
2003: Juliana Hwang; Michael H Ing; Adler Salazar; Bernard Lassègue; Kathy K Griendling; Mohamad Navab; Alex Sevanian; Tzung K Hsiai
Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation.
Circulation research 2003;93(12):1225-32.
2003: Benjamin J Ansell; Mohamad Navab; Susan Hama; Naeimeh Kamranpour; Gregg C Fonarow; Greg Hough; Shirin Rahmani; Rachel Mottahedeh; Ravi Dave; Srinivasa T Reddy; Alan M Fogelman
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Circulation 2003;108(22):2751-6.
2003: Mohamad Navab; Susan Hama; Greg Hough; Alan M Fogelman
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice.
Circulation 2003;108(14):1735-9.
2003: Mohamad Navab; Gm Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Greg Hough; Alan Wagner; Kenta Nakamura; David W Garber; Geeta Datta; Jere P Segrest; Susan Hama; Alan M Fogelman
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Current opinion in investigational drugs (London, England : 2000) 2003;4(9):1100-4.
2003: Tzung K Hsiai; Sung K Cho; Pak K Wong; Michael H Ing; Adler Salazar; Alex Sevanian; Mohamad Navab; Linda L Demer; Chih-Ming Ho
Monocyte recruitment to endothelial cells in response to oscillatory shear stress.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(12):1648-57.
2002: Srinivasa T Reddy; Susan Hama; Carey Ng; Victor Grijalva; Mohamad Navab; Alan M Fogelman
ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(11):1877-83.
2002: Brian J Van Lenten; Alan C Wagner; Gm Anantharamaiah; David W Garber; Michael C Fishbein; Lopa Adhikary; Debi P Nayak; Susan Hama; Mohamad Navab; Alan M Fogelman
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.
Circulation 2002;106(9):1127-32.
2002: Mohamad Navab; Susan Hama; Srinivasa T Reddy; Carey J Ng; Brian J Van Lenten; Hillel Laks; Alan M Fogelman; Srinu T Ready
Oxidized lipids as mediators of coronary heart disease.
Current opinion in lipidology 2002;13(4):363-72.
2002: Tzung K Hsiai; Sung K Cho; Henry M Honda; Susan Hama; Mohamad Navab; Linda L Demer; Chih-Ming Ho
Endothelial cell dynamics under pulsating flows: significance of high versus low shear stress slew rates (d(tau)/dt).
Annals of biomedical engineering 2002;30(5):646-56.
2002: Srinivasa T Reddy; Victor Grijalva; Carey Ng; Khaled Hassan; Susan Hama; Rachel Mottahedeh; David J Wadleigh; Mohamad Navab; Alan M Fogelman
Identification of genes induced by oxidized phospholipids in human aortic endothelial cells.
Vascular pharmacology 2002;38(4):211-8.
2002: Mohamad Navab; Gm Anantharamaiah; Susan Hama; David W Garber; Manjula Chaddha; Greg Hough; Roger Lallone; Alan M Fogelman
Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.
Circulation 2002;105(3):290-2.
2001: Carey J Ng; David J Wadleigh; A Gangopadhyay; Susan Hama; Victor Grijalva; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.
The Journal of biological chemistry 2001;276(48):44444-9.
2001: Mohamad Navab; Brian J Van Lenten; Srinivasa T Reddy; Alan M Fogelman
High-density lipoprotein and the dynamics of atherosclerotic lesions.
Circulation 2001;104(20):2386-7.
2001: Tzung K Hsiai; Sung K Cho; Srinivasa Reddy; Susan Hama; Mohamad Navab; Linda L Demer; H M Honda; Chih-Ming Ho
Pulsatile flow regulates monocyte adhesion to oxidized lipid-induced endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(11):1770-6.
2001: H M Honda; Tzung K Hsiai; C M Wortham; M Chen; H Lin; Mohamad Navab; Linda L Demer
A complex flow pattern of low shear stress and flow reversal promotes monocyte binding to endothelial cells.
Atherosclerosis 2001;158(2):385-90.
2001: Mohamad Navab; Susan Hama; Greg Hough; Ganesamoorthy Subbanagounder; Srinivasa T Reddy; Alan M Fogelman
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.
Journal of lipid research 2001;42(8):1308-17.
2001: Geeta Datta; Manjula Chaddha; Susan Hama; Mohamad Navab; Alan M Fogelman; David W Garber; Vinod K Mishra; Richard M Epand; Raquel F Epand; Sissel Lund-Katz; Michael C Phillips; Jere P Segrest; Gm Anantharamaiah
Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
Journal of lipid research 2001;42(7):1096-104.
2001: James H Dwyer; Mohamad Navab; Kathleen M Dwyer; Khaled Hassan; Ping Sun; Anne Shircore; S Hama-Levy; Greg Hough; X Wang; T Drake; C Noel Bairey Merz; Alan M Fogelman
Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study.
Circulation 2001;103(24):2922-7.
2001: S Reddy; Susan Hama; Victor Grijalva; Khaled Hassan; Rachel Mottahedeh; Greg Hough; David J Wadleigh; Mohamad Navab; Alan M Fogelman
Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells.
The Journal of biological chemistry 2001;276(20):17030-5.
2001: Brian J Van Lenten; Alan C Wagner; Debi P Nayak; Susan Hama; Mohamad Navab; Alan M Fogelman
High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.
Circulation 2001;103(18):2283-8.
2001: Brian J Van Lenten; Mohamad Navab; Diana M Shih; Alan M Fogelman; Aldons J Lusis
The role of high-density lipoproteins in oxidation and inflammation.
Trends in cardiovascular medicine 2001;11(3-4):155-61.
2001: Srinivasa T Reddy; David J Wadleigh; Victor Grijalva; Carey Ng; Susan Hama; A Gangopadhyay; Diana M Shih; Aldons J Lusis; Mohamad Navab; Alan M Fogelman
Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(4):542-7.
2001: Mohamad Navab; Judith A Berliner; Ganesamoorthy Subbanagounder; Susan Hama; Aldons J Lusis; Lawrence W Castellani; Srinivasa Reddy; Diana M Shih; Weibin Shi; Andrew D Watson; Brian J Van Lenten; Devendra K Vora; Alan M Fogelman
HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(4):481-8.
2001: David W Garber; Geeta Datta; Manjula Chaddha; Mayakonda N Palgunachari; Susan Hama; Mohamad Navab; Alan M Fogelman; Jere P Segrest; Gm Anantharamaiah
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.
Journal of lipid research 2001;42(4):545-52.
2001: Brian J Van Lenten; Alan C Wagner; Mohamad Navab; Alan M Fogelman
Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6.
The Journal of biological chemistry 2001;276(3):1923-9.
2000: Margarete Mehrabian; Lawrence W Castellani; Ping-Zi Wen; Jack Wong; T Rithaporn; Susan Hama; Greg Hough; D Johnson; J J Albers; Giuliano A Mottino; Joy S Frank; Mohamad Navab; Alan M Fogelman; Aldons J Lusis
Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei x C57BL/6J).
Journal of lipid research 2000;41(12):1936-46.
2000: Mohamad Navab; Susan Hama; Gm Anantharamaiah; Khaled Hassan; Greg Hough; Andrew D Watson; Srinivasa T Reddy; A Sevanian; Gregg C Fonarow; Alan M Fogelman
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
Journal of lipid research 2000;41(9):1495-508.
2000: Mohamad Navab; Susan Hama; C Justin Cooke; Gm Anantharamaiah; Manjula Chaddha; L Jin; Ganesamoorthy Subbanagounder; Kym F Faull; Srinivasa T Reddy; Norman E Miller; Alan M Fogelman
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.
Journal of lipid research 2000;41(9):1481-94.
2000: Catherine C Hedrick; Khaled Hassan; Greg Hough; J H Yoo; S Simzar; C R Quinto; S M Kim; Alek N Dooley; S Langi; Susan Hama; Mohamad Navab; Joseph L Witztum; Alan M Fogelman
Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(8):1946-52.
1999: Andrew D Watson; Ganesamoorthy Subbanagounder; Derek S Welsbie; Kym F Faull; Mohamad Navab; Michael E Jung; Alan M Fogelman; Judith A Berliner
Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein.
The Journal of biological chemistry 1999;274(35):24787-98.
1999: C Lee; F Sigari; T Segrado; Sohvi Hörkkö; S Hama; Papasani V Subbaiah; M Miwa; Mohamad Navab; J L Witztum; Peter D Reaven
All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(6):1437-46.
1999: Bert N La Du; Michael Aviram; Scott S Billecke; Mohamad Navab; SL Primo-Parmo; RC Sorenson; Theodore J Standiford
On the physiological role(s) of the paraoxonases.
Chemico-biological interactions 1999;119-120():379-88.
1999: Norbert Leitinger; Andrew D Watson; Susan Hama; BT Ivandic; Jian-Hua Qiao; J Huber; Kym F Faull; David Grass; Mohamad Navab; Alan M Fogelman; Frederick C de Beer; Aldons J Lusis; Judith A Berliner
Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(5):1291-8.
1999: BT Ivandic; Lawrence W Castellani; Xu-Ping Wang; Jian-Hua Qiao; Margarete Mehrabian; Mohamad Navab; Alan M Fogelman; David Grass; M E Swanson; Maria C de Beer; Frederick C de Beer; Aldons J Lusis
Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(5):1284-90.
1999: H M Honda; B K Wakamatsu; Joshua I Goldhaber; Judith A Berliner; Mohamad Navab; James N Weiss
High-density lipoprotein increases intracellular calcium levels by releasing calcium from internal stores in human endothelial cells.
Atherosclerosis 1999;143(2):299-306.
1998: Mohamad Navab; Susan Hama; Greg Hough; Catherine C Hedrick; RC Sorenson; Bert N La Du; J A Kobashigawa; Gregg C Fonarow; Judith A Berliner; Hillel Laks; Alan M Fogelman
High density associated enzymes: their role in vascular biology.
Current opinion in lipidology 1998;9(5):449-56.
1998: Shehla Pervin; Rajan Singh; M E Rosenfeld; Mohamad Navab; Gautam Chaudhuri; Lauren Nathan
Estradiol suppresses MCP-1 expression In vivo : implications for atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(10):1575-82.
1998: Diana M Shih; L Gu; Yu-Rong Xia; Mohamad Navab; Wan-Fen Li; Susan Hama; Lawrence W Castellani; Clement E Furlong; Lucio G Costa; Alan M Fogelman; Aldons J Lusis
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.
Nature 1998;394(6690):284-7.
1997: K Ishikawa; Mohamad Navab; Norbert Leitinger; Alan M Fogelman; Aldons J Lusis
Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.
The Journal of clinical investigation 1997;100(5):1209-16.
1997: Lawrence W Castellani; Mohamad Navab; Brian J Van Lenten; Catherine C Hedrick; Susan Hama; A M Goto; Alan M Fogelman; Aldons J Lusis
Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
The Journal of clinical investigation 1997;100(2):464-74.
1997: Judith A Berliner; Norbert Leitinger; A Watson; J Huber; Alan M Fogelman; Mohamad Navab
Oxidized lipids in atherogenesis: formation, destruction and action.
Thrombosis and haemostasis 1997;78(1):195-9.
1997: Andrew D Watson; Norbert Leitinger; Mohamad Navab; Kym F Faull; Sohvi Hörkkö; Joseph L Witztum; Wulf Palinski; D Schwenke; Robert G Salomon; Wei Sha; Ganesamoorthy Subbanagounder; Alan M Fogelman; Judith A Berliner
Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.
The Journal of biological chemistry 1997;272(21):13597-607.
1997: Mohamad Navab; S Hama-Levy; Brian J Van Lenten; Gregg C Fonarow; C J Cardinez; Lawrence W Castellani; Marie-Luise Brennan; Aldons J Lusis; Alan M Fogelman; Bert N La Du
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
The Journal of clinical investigation 1997;99(8):2005-19.
1996: Mohamad Navab; Judith A Berliner; Andrew D Watson; Susan Hama; Mary Territo; A J Lusis; D M Shih; Brian J Van Lenten; J S Frank; Linda L Demer; P A Edwards; Alan M Fogelman
The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(7):831-42.
1996: Diana M Shih; L Gu; Susan Hama; Yu-Rong Xia; Mohamad Navab; Alan M Fogelman; A J Lusis
Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.
The Journal of clinical investigation 1996;97(7):1630-9.
1995: Andrew D Watson; Judith A Berliner; Susan Hama; Bert N La Du; Kym F Faull; Alan M Fogelman; Mohamad Navab
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
The Journal of clinical investigation 1995;96(6):2882-91.
1995: Brian J Van Lenten; Susan Hama; Frederick C de Beer; D M Stafforini; T M McIntyre; S M Prescott; Bert N La Du; Alan M Fogelman; Mohamad Navab
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
The Journal of clinical investigation 1995;96(6):2758-67.
1995: Mohamad Navab; Alan M Fogelman; Judith A Berliner; Mary Territo; Linda L Demer; J S Frank; Andrew D Watson; P A Edwards; A J Lusis
Pathogenesis of atherosclerosis.
The American journal of cardiology 1995;76(9):18C-23C.
1995: Brian J Van Lenten; J Prieve; Mohamad Navab; Susan Hama; A J Lusis; Alan M Fogelman
Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo.
The Journal of clinical investigation 1995;95(5):2104-10.
1995: J A Berliner; Mohamad Navab; A M Fogelman; J S Frank; Linda L Demer; P A Edwards; A D Watson; A J Lusis
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.
Circulation 1995;91(9):2488-96.
1995: Andrew D Watson; Mohamad Navab; Susan Hama; A Sevanian; S M Prescott; D M Stafforini; T M McIntyre; B N Du; Alan M Fogelman; Judith A Berliner
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
The Journal of clinical investigation 1995;95(2):774-82.
1994: Peter D Reaven; E Ferguson; Mohamad Navab; F L Powell
Susceptibility of human LDL to oxidative modification. Effects of variations in beta-carotene concentration and oxygen tension.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(7):1162-9.
1994: Mohamad Navab; Susan Hama; T B Nguyen; Alan M Fogelman
Monocyte adhesion and transmigration in atherosclerosis.
Coronary artery disease 1994;5(3):198-204.
1993: A J Lusis; Mohamad Navab
Lipoprotein oxidation and gene expression in the artery wall. New opportunities for pharmacologic intervention in atherosclerosis.
Biochemical pharmacology 1993;46(12):2119-26.
1993: Mohamad Navab; Susan Hama; Brian J Van Lenten; D C Drinkwater; H Laks; Alan M Fogelman
A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells.
The Journal of clinical investigation 1993;91(3):1225-30.
1993: R L Bennett; Mohamad Navab; Linda L Demer; Alan M Fogelman
A new anti-inflammatory leucine derivative, NPC-15669, inhibits growth of cultured human aortic smooth muscle cells.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(3):360-6.
1992: Judith A Berliner; Mary Territo; Mohamad Navab; A Andalibi; Farhad Parhami; F Liao; J Kim; S Estworthy; A J Lusis; Alan M Fogelman
Minimally modified lipoproteins in diabetes.
Diabetes 1992;41 Suppl 2():74-6.
1992: J A Berliner; Mohamad Navab; T A Drake; A M Fogelman
Do dietary fatty acids cause endothelial activation? How might endothelial activation contribute to thrombogenesis?
The American journal of clinical nutrition 1992;56(4 Suppl):804S.
1991: Mohamad Navab; S S Imes; Susan Hama; G P Hough; L A Ross; R W Bork; Anthony Valente; Judith A Berliner; D C Drinkwater; H Laks
Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.
The Journal of clinical investigation 1991;88(6):2039-46.
1991: F Liao; Judith A Berliner; Margarete Mehrabian; Mohamad Navab; Linda L Demer; A J Lusis; Alan M Fogelman
Minimally modified low density lipoprotein is biologically active in vivo in mice.
The Journal of clinical investigation 1991;87(6):2253-7.
1991: Mohamad Navab; F Liao; G P Hough; L A Ross; Brian J Van Lenten; Tripathi B Rajavashisth; A J Lusis; H Laks; D C Drinkwater; Alan M Fogelman
Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message.
The Journal of clinical investigation 1991;87(5):1763-72.
1990: G P Hough; L A Ross; Mohamad Navab; Alan M Fogelman
Transport of low density lipoproteins across endothelial monolayers.
European heart journal 1990;11 Suppl E():62-71.
1990: S D Cushing; Judith A Berliner; Anthony Valente; Mary Territo; Mohamad Navab; Farhad Parhami; Ross G Gerrity; C J Schwartz; Alan M Fogelman
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(13):5134-8.
1990: Tripathi B Rajavashisth; A Andalibi; Mary Territo; Judith A Berliner; Mohamad Navab; Alan M Fogelman; A J Lusis
Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins.
Nature 1990;344(6263):254-7.
1988: Mohamad Navab; G P Hough; L W Stevenson; D C Drinkwater; H Laks; Alan M Fogelman
Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells.
The Journal of clinical investigation 1988;82(6):1853-63.
1988: D D Thomas; Mohamad Navab; David A Haake; Alan M Fogelman; James N Miller; Michael A Lovett
Treponema pallidum invades intercellular junctions of endothelial cell monolayers.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(10):3608-12.
1988: Alan M Fogelman; Judith A Berliner; Brian J Van Lenten; Mohamad Navab; Mary Territo
Lipoprotein receptors and endothelial cells.
Seminars in thrombosis and hemostasis 1988;14(2):206-9.
1988: Mohamad Navab; G P Hough; Brian J Van Lenten; Judith A Berliner; Alan M Fogelman
Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form.
The Journal of clinical investigation 1988;81(2):601-5.
1986: Mohamad Navab; G P Hough; Judith A Berliner; J A Frank; Alan M Fogelman; Margaret Haberland; Peter A Edwards
Rabbit beta-migrating very low density lipoprotein increases endothelial macromolecular transport without altering electrical resistance.
The Journal of clinical investigation 1986;78(2):389-97.